{"id":7134,"date":"2025-09-25T23:02:20","date_gmt":"2025-09-25T23:02:20","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/09\/25\/readout-loud-podcast-huntingtons-uniqure-autism-trump-tylenol-leucovorin\/"},"modified":"2025-09-25T23:02:20","modified_gmt":"2025-09-25T23:02:20","slug":"readout-loud-podcast-huntingtons-uniqure-autism-trump-tylenol-leucovorin","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/09\/25\/readout-loud-podcast-huntingtons-uniqure-autism-trump-tylenol-leucovorin\/","title":{"rendered":"A gene therapy success in Huntington\u2019s and Trump\u2019s autism announcement"},"content":{"rendered":"<p>    A gene therapy success in Huntington\u2019s and Trump\u2019s autism announcement<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p>Why were doctors and investors so excited about trial results of UniQure\u2019s gene therapy for Huntington\u2019s disease? Are autism rates actually rising? And what does the research tell us about Tylenol and autism?<\/p>\n<p>We discuss all that on this week\u2019s episode of the \u201cThe Readout LOUD,\u201d STAT\u2019s biotech podcast. We bring on UniQure CEO Matt Kapusta to discuss the company\u2019s announcement this week that its one-time treatment for Huntington\u2019s disease significantly slowed down the neurological condition in a key study.<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2025\/09\/25\/readout-loud-podcast-huntingtons-uniqure-autism-trump-tylenol-leucovorin\/?utm_campaign=rss\">Read the rest\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Elaine Chen, Adam Feuerstein, and Allison DeAngelis<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2025\/09\/25\/readout-loud-podcast-huntingtons-uniqure-autism-trump-tylenol-leucovorin\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A gene therapy success in Huntington\u2019s and Trump\u2019s autism announcement Why were doctors and investors so excited about trial results of UniQure\u2019s gene therapy for Huntington\u2019s disease? Are autism rates actually rising? And what does the research tell us about Tylenol and autism? We discuss all that on this week\u2019s episode of the \u201cThe Readout [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2471,2154,2238,3889,2678,2265],"tags":[2150],"class_list":["post-7134","post","type-post","status-publish","format-standard","hentry","category-autism","category-biotechnology","category-disability","category-neurology","category-rare-diseases","category-the-readout-loud","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/7134"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=7134"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/7134\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=7134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=7134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=7134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}